Eli Lilly and Firm LLY introduced that it has entered right into a collaboration with Vir Biotechnology, Inc. VIR and GlaxoSmithKline plc GSK for growing a mix routine of its COVID-19 drug, bamlanivimab (LY-CoV555). www.nasdaq.com
Eli Lilly and Firm LLY introduced that it has entered right into a collaboration with Vir Biotechnology, Inc. VIR and GlaxoSmithKline plc GSK for growing a mix routine of its COVID-19 drug, bamlanivimab (LY-CoV555).
www.nasdaq.com